ATLANTA - The cost of treating cancer in the United States nearly doubled over the past two decades, but expensive cancer drugs may not be the main reason why.

CHICAGO --- A drug to prevent bone loss during breast cancer treatment also substantially cut the risk that the cancer would return, results that left doctors excited about a possible new way to fight the disease.

...Hospital in Pittsburgh. He led the study and reported results Saturday at a meeting in Atlanta of the American Society of Clinical Oncology. Tykerb's manufacturer, British-based GlaxoSmithKline PLC, paid for the study and said it would...

The worst part of being treated for advanced skin cancer is the flu-like aftershock from chemotherapy that lays out Mary Cayer in front of her four young children.

WASHINGTON -- Heart disease and diabetes get all the attention, but expanding waistlines increase the risk for at least nine types of cancer, too. And with the obesity epidemic showing no signs of waning, specialists say they need to better understand how fat cells fuels cancer growth so they might fight back.

...for their practice expenses and complain that the new law does not do enough to address that issue. The American Society of Clinical Oncology has asked Congress to essentially freeze payments at current levels until various agencies complete studies...

...important," said Vanderbilt University lung cancer specialist Dr. David Johnson, president-elect of the American Society of Clinical Oncology. "This is just the beginning of personalized medicine." But it also raises some intriguing questions...

October is Breast Cancer Awareness Month. About 3-million women in the United States are living with breast cancer: 2-million who have been diagnosed and an estimated 1-million who do not yet know they have the disease, reports the National Breast Cancer Coalition. "There is nothing a woman can do to ensure that she will not get breast cancer," the coalition says. But Breast Cancer Awareness Month reminds every woman that early detection is critical and an annual mammogram her best defense. No one knows what causes breast cancer.

...singles and doubles. This is a home run," said Dr. Charles Balch, executive vice president of the American Society of Clinical Oncology. The latest findings were presented in San Francisco at the society's annual meeting by Dr. Ronald...

...mid-size studies of these medicines were reported at this week's annual cancer conference sponsored by the American Society of Clinical Oncology. Together, experts say, these studies offer proof that the concept is sound: Attacking tumors' ability...